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The emergence of carbapenem-resistant Enterobacteriaceae (CRE) has become a major
public health concern worldwide and a new challenge in the treatment of infectious
diseases. The molecular characteristics of Enterobacter cloacae in Ningxia China are
unknown. In this study, we reported 10 carbapenem-resistant E. cloacae isolates from
the General Hospital of Ningxia Medical University, the largest university hospital in
Ningxia between January 2012 and December 2013. Bacteria isolates were identified
by Vitek2 compact and the identity of non-duplicate E. cloacae isolates was further
confirmed by PCR and sequencing. The drug susceptibility and phenotype identification
of these isolates were analyzed by agar dilution method, modified Hodge test (MHT),
and EDTA synergy test. Beta-lactamase (bla) genes blaNDM−1 was found in 8 out
of 10 isolates. Most isolates harbored multiple resistance genes including blaESBL,
blaAmpC, quinolones, aminoglycosides, and disinfectant resistance genes. Pulsed field
gel electrophoresis (PFGE) showed that these E. cloacae isolates were grouped into
6 clusters based on a cutoff of 80% genetic similarity. In conjugative assay, 9 out of
10 isolates transferred carbapenem-resistant genes to Escherichia coli. Our study has
revealed that NDM-1-producing isolates are the most prevalent carbapenem-resistant
E. cloacae in Ningxia. These isolates also carry several other carbapenem-resistant genes
and can transfer these genes to other bacteria through conjugation. These findings
highlight an urgent need to monitor these isolates to prevent their further spread in this
region.
Keywords: Enterobacteriaceae, carbapenem resistance, antibiotic susceptibility, New Delhi metallo-beta-
lactamase-1, genetic homologeneity
INTRODUCTION
The Enterobacteriaceae are a large family of Gram-negative bacteria that may cause several
infectious diseases such as respiratory tract infection, intra-abdominal infection, urinary
tract infection, etc. (Wang J. T. et al., 2015). Carbapenem has been the main treatment
for severe infections associated with Enterobacteriaceae (Kaniga et al., 2010). Nevertheless,
carbapenem-resistant Enterobacteriaceae (CRE) has gradually emerged and becomes one of the
serious public health concerns worldwide (Alam et al., 2014; Ling et al., 2015; Xu et al., 2015; Iredell
et al., 2016). According to the 2012 CHINET report on CRE in China, the domestic incidence of
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CRE has increased 2.2-fold between 2010 and 2012 (Hu et al.,
2012). Carbapenem resistance in Enterobacteriaceae is mainly
mediated by the production of carbapenemases, a form of β-
lactamase, that cleave the β-lactam ring, an essential component
of β-lactam antibiotics such as cephalosporins and carbapenems
(Queenan and Bush, 2007).
Enterobacter cloacae, a species of the Enterobacteriaceae
family, is an important nosocomial pathogen that may cause
infections in wound, urinary tract, lower respiratory tract, skin
and soft tissues. While CRE infections are primarily caused
by Klebsiella pneumoniae and Escherichia coli (Goodman et al.,
2016), carbapenem-resistant E. cloacae has only occasionally
been reported (Bennett et al., 2009; Heller et al., 2012). In this
study, we reported 10 carbapenem-resistant E. cloacae isolated
in the largest university hospital in Ningxia province, China and
investigated their molecular characteristics.
MATERIALS AND METHODS
Reagents
Imipenem, meropenem, ceftazidime, and tigecycline was
purchased from Pfizer. MH agar was purchased from OXOID.
Primers were synthesized by Sangon Biotech Shanghai Co. Ltd.
Premix Taq was purchased from Takara Biotech Dalian Co. Ltd.
Xba I restriction enzymes were purchased from Thermo.
Sample Collection, Bacterial Identification,
and Reference Strains
Bacterial isolates were collected from the General Hospital of
Ningxia Medical University, a large-sized hospital in Ningxia
province, China, between January 2012 and December 2013.
Species identification and initial drug susceptibility were
analyzed by Vitek2 compact (bioMerieux, France). E. coli
ATCC25922, Klebsiella pneumonia ATCC BAA-1705, and
K. pneumonia ATCC BAA-1706 were used as quality control
strains.
Identification of E. cloacae by PCR and
Sequencing
The identity of all E. cloacae isolates was further confirmed
by PCR and sequencing. Briefly, the isolates were cultured
by standard methods. To isolate chromosomal DNA, one
freshly grown colony was scraped into an Eppendorf tube and
resuspended in 200 µL of sterile water. The bacterial suspension
was boiled at 100◦C for 10 min to release the genomic DNA. The
DNA was then used as the template to amplify the 16S rRNA
gene segment (1465 bp) by PCR. The sequences of primers: 27F:
AGA GTT TGA TCM TGG CTC AG, and 1492R: TAC GGY
TAC CTTGTT ACGACT T. The PCR programs were as follows:
denaturation at 94◦C 5 min, followed by 30 cycles of 94◦C 30 s,
55◦C 40 s, and 72◦C 1min, and extension at 72◦C 5min. The PCR
products were sequenced by BGI Genomics (Beijing, China).
Drug Susceptibility Test and Phenotype
Identification
The antibiotic susceptibilities of the E. cloacae isolates were tested
by measuring the minimal inhibitory concentration (MIC) for
imipenem, meropenem and tigecycline using the agar dilution
method. Imipenem and meropenem results were interpreted
according to the Clinical Laboratory Standards Institute (CLSI)
guidelines (2013). Freshly prepared tigecycline (<12 h old) was
used, and results were interpreted based on the FDA criteria
(R:MIC ≥ 8, I:MIC = 4, S:MIC ≤ 2). All E. cloacae isolates
were screened for carbapenemase production by the modified
Hodge test (MHT) and EDTA synergy test according to the CLSI
guidelines. In EDTA synergy test, 0.5M units bacterial sample was
spread on MH agar plate. Two meropenem disks were placed on
the plate with a distance of 15–20 mm. Aliquots of EDTA (10 µL
of 0.5 mol/L solution) was added onto one of the disks, and the
plate was incubated at 35◦C for 18–24 h. A positive result was
scored when the diameter of the inhibition zone around EDTA
disk was 5 mm larger than that around the other disk. Both MHT
and EDTA synergy test were performed in triplicates.
Detection of Resistance Genes
The DNA was extracted from each carbapenem-resistant
E. cloacae isolate. Resistance genes were detected by PCR,
including extended-spectrum β-lactamases (ESBL: blaTEM,
blaSHV, blaCTX, blaVEB, blaPER, and blaSFO), AmpC enzyme
(blaDHA, blaEBC, blaACC, blaCIT, and blaMOX), carbapenemase
(blaKPC, blaNDM−1, blaSME, blaIMP, blaVIM, blaOXA−23, and
blaOXA−48), class 1 and 2 integron, and other resistant genes
(qnrA, qnrB, qnrS, acc-Ib, qac1E, and sul). The reaction system
(25 µL) was prepared: Premix Taq 12.5 µL, template 2 µL, each
primer 0.2 µL (∼10µM), and sterile water 10.1 µL. Reaction
program was as follows: 94◦C denaturation for 5 min, followed
by 30 cycles of 94◦C denaturation for 45 s, 52–58◦C annealing
for 45 s, 72◦C extension for 1 min, 72◦C final extension for 10
min. Positive amplification products were sequenced and the
sequencing results were compared by BLAST.
Genetic Homologeity Analysis
All carbapenem-resistant E. cloacae were analyzed by pulsed
field gel electrophoresis (PFGE) to determine their genetic
homologeity. The bacterial DNA embedded in small plastic
pieces was treated with proteinase K and cleaved by the
restriction enzyme XbaI at 37◦C for 12–14 h. The XbaI-digested
DNA was analyzed by electrophoresis for 21 h at 6 V/cm, with
a pulse angle of 120◦ and pulse times from 2.16 to 63.8 s. PFGE
was performed in triplicates. Comparison of the PFGE patterns
was performedwith Bionumerics software based on the Tenover’s
criteria (Tenover et al., 1995). Isolates were allocated into genetic
similarity clusters using a cut-off value of 80%.
Plasmid Conjugation Test
The conjugation test was performed by the broth mating method
using carbapenem-resistant E. cloacae as the donor strain and
rifampin-resistant E. coli EC600 as the recipient strain. The donor
and recipient strain were inoculated respectively in 5 mL LB,
and was incubated in a thermostatic shaker at 37◦C for 18–
24 h. The donor strain (60 µL) and recipient strain (90 µL) were
inoculated into 20ml of LB medium and incubated 37◦C for
18–24 h without any shaking. Transconjugants were selected on
MH agar plates containing 30 µg/mL ceftazidime + 400 µg/mL
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rifampicin and plates with 1 µg/mL imipenem + 400 µg/mL
rifampicin. The donor and recipient strains were used as negative
controls. The transconjugants strains were identified by PCR and
sequencing. TheMIC for imipenem, meropenem, and tigecycline
was measured by the agar dilution method. The conjugation test
was performed in triplicates
RESULTS
Phenotype and Genotype of
Carbapenem-Resistant E. cloacae Isolates
A total of 18 non-duplicate CRE isolates were identified from
2012 to 2013, 10 of which were E. cloacae. Eight and nine
positive E. cloacae isolates were detected in the MHT and
EDTA double disk synergy test, respectively. PCR amplification
showed that these E. cloacae isolates carried multiple resistant
genes. Integrons and insertion sequence common regions
(ISCR) were present in 8 and 9 out of 10 E. cloacae isolates,
respectively. As shown in Table 1, the carbapenem-resistant gene
was primarily New Delhi metallo-beta-lactamase-1 (blaNDM−1,
8/10), followed by K. pneumoniae carbapenemase (blaKPC, 6/10).
ESBL, AmpC, quinolones, aminoglycosides and disinfectant
resistance gene was found in 7, 8, 8, 4, and 8 out of 10 isolates,
respectively.
Molecular Epidemiology
Based on a cutoff of 80% genetic similarity, these isolates were
grouped into A (isolate No: 9, 11, 18, 03), B (isolate No: 33), C
(isolate No: 42), D (isolate No: 55), E (isolate No: 40, 56), and F
(isolate No: 02) clusters (Figure 1).
Plasmid Conjugation Test
The plasmid transconjugant test was performed for each
carbapenem-resistant E. cloacae isolate. The transconjugants
were analyzed by PCR and sequencing. Results showed that a
total of 9 transconjugants were E. coli, indicating the successful
transfer of resistant plasmid from E. cloacae isolate to E. coli.
TheMIC of the 9 transconjugants for imipenem,meropenem and
tigecycline was measured by the agar dilution method (Table 2).
DISCUSSION
Carbapenem-resistant E. cloacae can markedly prolong the
hospital length of stay, increase the medical cost, and most
importantly cause high mortality rate. With the wide spread of
CRE and associated resistant genes around the word (Castanheira
et al., 2013; Poirel et al., 2014; Zweigner et al., 2014; Jakobsen
et al., 2015), it has become urgent to investigate the epidemiology
and molecular characteristics of carbapenem-resistant E. cloacae,
which may provide a solid basis for an effective control of
carbapenem-resistant E. cloacae.
In this study, 55.6% of the carbapenem-resistant E. cloacae
isolated in our hospital can produce carbapenemase, which is
substantially different from the CHINET report (Ling et al.,
2015). The finding has reflected the distinct distribution of
the bacteria in this region, which might be related to the
antibiotic-prescribing habits of local doctors. After NDM-1 was
first reported by Kumarasamy in 2010 (Wang et al., 2011),
NDM-1-producing E. cloacae have been identified throughout
the world (Gupta et al., 2011; Ho et al., 2012). In China,
FIGURE 1 | Dendrogram showing pulsed-field gel electrophoresis
(PFGE) analysis of the 10 carbapenem-resistant E. cloacae isolates.
TABLE 1 | Summary of resistant genes detected in the carbapenem-resistant E. cloacae isolates.
Isolate ID MHT/EDTA double-disk synergy test Associated resistance determinants
β-lactamase gene Others
3 +/+ blaTEM, blaKPC, blaNDM−1, blaIMP, blaVIM qac1E, IntI, ISCR
9 +/+ blaCTX−1, blaEBC, blaKPC, blaNDM−1, blaVIM acc-Ib, qac1E, sul, IntI, ISCR
11 +/+ blaACC, blaEBC, blaKPC, blaNDM−1 qnrA, qac1E, IntI, ISCR
18 +/+ blaCTX−1, blaEBC, blaKPC, blaNDM−1 qnrA, qac1E, sul, IntI, ISCR
40 ± blaTEM, blaSHV, blaACC, blaEBC, blaNDM−1, blaVIM acc-Ib, qac1E, sul, IntI, ISCR
42 +/+ blaTEM, blaKPC, blaNDM−1, blaVIM qnrS, acc-Ib, qac1E, sul, IntI, ISCR
55 +/+ blaIMP –
56 +/+ blaTEM, blaDHA, blaEBC, blaNDM−1 acc-Ib, qac1E, sul, IntI, ISCR
02 −/− blaACC, blaEBC ISCR
03 +/+ blaCTX−1, blaDHA, blaEBC, blaKPC, blaNDM−1, blaVIM qnrA, qac1E, sul, IntI, ISCR
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TABLE 2 | Minimum inhibitory concentrations (MIC) for imipenem, meropenem and tigecycline of the carbapenem-resistant E. cloacae isolates and their
transconjugants.
Isolate S/F IPM TC-IPM MEM TC-MEM Tigecycline TC-Tigecycline
3 S 4 4 8 8 1 1
9 S 64 4 32 1 1 ≤0.125
11 S ≥128 4 ≥128 4 0.5 1
18 S 64 2 32 8 8 1
40 S 64 32 32 32 8 8
42 S 8 4 8 16 8 2
55 S 4 4 4 4 32 8
56 S 32 32 32 16 8 4
02 F – – – – – –
03 S 16 4 8 4 0.5 1
EC600 – 0.5 – ≤0.125 – ≤0.125 –
S/F, success/failure; IMP, impipenem; MEM, meropenem; TC, transconjugant strain; and EC600, recipient strain.
NDM-1 was initially detected in Ningxia province and has
been later reported in other regions (Ho et al., 2012; Huang
et al., 2015; Zhang et al., 2015). In this study, the carbapenem-
resistant gene is primarily blaNDM−1, and other carbapenemase
genes are also detected including blaKPC, imipenem-hydrolizing-
lactamase gene (blaIMP), andVerona imipenemase gene (blaVIM).
Inconsistent with our results, blaKPC−2 and blaVIM−1 were
identified as the primary carbapenem-resistant genes of CRE
isolates (Levy Hara et al., 2013; Li et al., 2014; Villa et al., 2014).
More importantly, in our study, non-carbapenemase-producing
resistant genes such as β-lactamase, quinolones, aminoglycosides,
etc. were detected. The gene of integration, ISCR and other
genetic elements were also identified in these isolates, suggesting
the possibility of exogenous gene transfer. Two of the isolates
even carry six β-lactamases and some other resistance genes. Our
results have revealed a diversity of resistance genes in our isolates,
indicating that these isolates might have achieved resistance
through different mechanisms.
Ningxia province, a relatively less developed region in
the northwest of China, has a much lower risk of bacterial
transmission compared with other regions (Hu et al., 2014;
Ling et al., 2015). In this study, the patients carrying the
carbapenem-resistant E. cloacae isolates had no prior travel
or living in any epidemic areas, indicating that these isolates
might have acquired the carbapenem resistance gene through
a unusual way. Moreover, Acinetobacter baumannii had been
previously isolated from 6 of these carrying patients, suggesting
the probable transmission of resistant genes between different
bacterial species. Such cross-species gene transmissions have
been previously detected (Bogaerts et al., 2013; Wang X. et al.,
2015).
MHT is recommended for the carbapenemas phenotype
identification test for by CLSI. Studies have shown that the
sensitivity of MHT for some strains is much higher compared
with others containing IMP, VIM, and NDM (a sensitivity
of 50%; Girlich et al., 2012; Ramana et al., 2013). In this
study, the positive rate of MHT is 8/10, indicating the
occurrence of false negative, which might be associated with
the production of IMP, VIM, and NDM in some isolates.
EDTA can inactivate the type B carbapenemas by chelating
Zn ions (Miriagou et al., 2013), resulting in the expansion
of the inhibition zone in EDTA synergy test. In this study,
the positive rate of EDTA synergy test is 9/10, and most
of the positive strains produce the type B carbapenemas.
Although, Azimi et al. have suggested that false negative
results are associated with the test method instead of the
type of carbapenemases (Azimi et al., 2016), Wang et al. have
reported a false positive rate of 3.3% in MHT due to the
low ertapenem hydrolysis capacity of ESBL, especially CTX-M
(Wang et al., 2011). Therefore, a combination examination of
carbapenemas phenotype by MHT and EDTA synergy test can
improve the sensitivity and specificity of carbapenemas gene
detection. Moreover, PCR method remains the gold standard
for carbapenemas phenotype identification (Rastegar Lari et al.,
2013). Consistently, the positive rate of PCR in our study
is 10/10.
In this study, based on a cutoff of 80% genetic similarity,
PFGE analysis revealed a high degree of genetic homologeity
among 5 isolates, suggesting that small-scale epidemic spread
might have occurred. Further transconjugation assay has
detected a positive rate of 9/10, which is markedly higher
than that in a previous study (Fu et al., 2012). The finding
suggests that our carbapenemase-producing E. cloacae
can transfer the resistant genes to susceptible bacterium,
leading to horizontal transfer of resistant genes, and thus
an infection outbreak of the pathogens. Furthermore, our
study also showed that the MIC of most transconjugates for
imipenem, meropenem, and tigecycline was lower compared
with their donor bacteria, indicating that the bacterial
resistance is dependent on several factors. The mechanism
of clinical transmission among different bacteria needs further
investigation.
In summary, our study demonstrated that NDM-1-producing
isolates were the most prevalent carbapenem-resistant E. cloacae
in Ningxia province, China. These isolates can transfer
the resistant gene to other bacteria through conjugation.
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To our best knowledge, this is the first report on the
prevalence andmolecular characteristics of carbapenem-resistant
E. cloacae in, China. Early detection and surveillance of these
E. cloacae isolates are urgently needed to prevent their further
spread.
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